Influence of gadolinium-induced Kupffer cell blockade on portal venous tolerance in rat skin allograft transplantation

European Surgical Research

Volumn 37, Issue 1, 2005, Pages 45-49

  Diaz Peromingo, J A ^a   Gonzalez Quintela, A ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Gadolinium; Kupffer cells; Skin allograft; Tolerance, portal venous; Transplantation, skin

Indexed keywords

GADOLINIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; JUGULAR VEIN; KUPFFER CELL; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; SKIN ALLOGRAFT;

ANIMALS; BLOOD TRANSFUSION; GADOLINIUM; GRAFT SURVIVAL; KUPFFER CELLS; MALE; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SKIN TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 17844374893     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083147     Document Type: Article

References (30)

1. Cantor H, Dumont A: Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 1967;215:744-745.
2. Chase M: Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 1946;62:257.
3. Callery MP, Kamei T, Flye MW: Kupffer cell blockade inhibits induction of tolerance by the portal venous route. Transplantation 1989;47:1092-1094.
4. Kamei T, Callery MP, Flye MW: Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990;48:393-396.
5. Kamei T, Callery MP, Flye MW: Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival. Surgery 1990;108:415-421.
6. Squiers EC, Salomon DR, Pickard LL, Howard RR, Pfaff WW: Abrogation of the induction of portal venous tolerance in a cardiac transplant model resulting from Kupffer cell inhibition by gadolinium. Transplantation 1990;50:171-173.
7. Sato K, Yabuki K, Haba T, Maekawa T: Role of Kupffer cells in the induction of tolerance after liver transplantation. J SurgRes 1996;63:433-438.
8. Yu S, Nakafusa Y, Flye MW: In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells. Transplantation 1997;64:1684-1688.
9. Jin T, Toki J, Inaba M, Sugiura K, Fan T, Yu C, Lian Z, Takase K, Feng B, Ito T, Cui Y, Yang G, Ikehara S: A novel strategy for organ allografts using sublethal (7 Gy) irradiation followed by injection of donor marrow cells via portal vein. Transplantation 2001;71:1725-1731.
10. Margenthaler JA, Landeros K, Kataoka M, Flye MW: Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice. Transplant Immunol 2003;11:23-29.
11. Boeckx W, Sobis H, Lacquet A, Gruwez J, Vandeputte M: Prolongation of allogeneic heart graft survival in the rat after implantation on portal vein. Transplantation 1975;19:145-149.
12. Schraut W, Rosemurgy A, Riddle R: Prolongation of intestinal allograft survival without immunosuppressive drug therapy. Transplantation of small bowel allografts. J Surg Res 1983;34:597-607.
13. Vidal C, González-Quintela A, Cuervas-Mons V:Influence of Kupffer cell phagocytosis blockade of the production of ovalbumin-specific IgE and IgG1 antibodies in an experimental model. Clin Exp Allergy 1993;23:15-20.
14. Margenthaler JA, Landeros K, Kataoka M, Flye MW: CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction. J Surg Res 2002;104:29-35.
15. Sato Y, Ichida T, Watanabe H, Yamamoto S, Oya H, Nakatsuka H, Kobayashi T, Watanabe T, Kameyama H, Hatakeyama K: Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation. Hepatogastroen-terology 2003;50:601-606.
16. Pirenne J, Koshiba T, Geboes K, Emonds MP, Ferdinande P, Hiele M, Nevens F, Waer M: Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Transplantation 2002;73:966-968.
17. Watanabe T, Katsukura H, Shirai Y, Yamori M, Nishi T, Chiba T, Kita T, Wakatsuki Y: A liver tolerates a portal antigen by generating CD11c+ cells, which select Fas ligand+ Th2 cells via apoptosis. Hepatology 2003;38:403-412.
18. Roland CR, Mangino MJ, Duffy BF, Flye MW: Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: A study of macrophage function after intravenous gadolinium. Transplantation 1993;55: 1151-1158.
19. Squiers EC, Brunson ME, Salomon DR: Kupffer cells can present alloantigen in vitro: An effect abrogated by gadolinium. J Surg Res 1993;55:571-574.
20. Husztik E, Lazar G, Parducz A: Electron microscopic study of Kupffer-cell phagocytosis blockade induced by gadolinium chloride. Br J Exp Pathol 1980;61:624-630.
21. Hardonk MJ, Dijkhuis FW, Hulstaert CE, Koudstaal J: Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 1992;52:296-302.
22. Guillen F, Hancock W, Towpik E, Kupiec-Weglinski JW, Rickles FR, Tilney NL, Murphy GF: Inhibition of rat skin allograft rejection by cyclosporine. In situ characterization of the impaired local immune response. Transplantation 1986;41:734-739.
23. Hardy MA, Agrawal S, Suciu-Foca N: Experimental and clinical tolerance induction. Transplant Proc 1998;30:2435-2437.
24. Gruessner RW, Levay-Young BK, Nakhaleh RE, Shearer JD, Dunning M, Nelson CM, Gruessner AC: Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation. Transplantation 2004;77:1500-1506.
25. Nakafusa Y, Terasaka R, Matsuo K, Konomi K, Flye MW: Advantages of donor-specific blood transfusion in the rat via the portal vein for renal transplantation. Am J Kidney Dis 1993;21:433-438.
26. Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB: Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995;60:1395-1401.
27. Wang YB, Ogawa Y, Doi H, Kusumoto K, Jin TN, Ikehara S: Long-term immunologic induction of donor-specific tolerance to skin allografts by bone marrow transplant in rabbits. Plast Reconstr Surg 2003;111:291-297.
28. Kara E, Gokhan I, Dayangac M, Ilkgul O, Ertan H, Tokat Y, Terzioglu E: Effect of portal venous injection of donor spleen cells on skin graft allograft survival in rat. Indian J Med Res 2004;119:110-114.
29. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP: The liver as a site of T-cell apoptosis: Graveyard, or killing field? Immunol Rev 2000;174:47-62.
30. Knolle PA, Gerken G: Local control of the immune response in the liver. Immunol Rev 2000;174:21-34.